SCHEDULE: Millennium Entities Disclose 3% Stake in Fulgent Genetics

Millennium Management LLC and affiliated entities have filed an amended Schedule 13G, reporting a 3.0% beneficial ownership in Fulgent Genetics, Inc. as of December 31, 2025.

Summary

• Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander collectively reported beneficial ownership of Fulgent Genetics, Inc. common stock.
• Integrated Core Strategies (US) LLC beneficially owns 918,503 shares, representing 3.0% of the class.
• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each beneficially own 939,375 shares, also representing 3.0% of the class.
• The reporting persons share voting and dispositive power over their respective reported shares.
• The filing certifies that the securities were not acquired or held for the purpose of changing or influencing the control of Fulgent Genetics, Inc.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, as a significant institutional investor maintains a passive stake, suggesting continued confidence without indicating any immediate activist intentions.

Positives

• A significant institutional investor, Millennium Management LLC and its affiliates, maintains a notable stake in Fulgent Genetics, Inc., indicating continued interest.
• The filing confirms that the investment is passive, not intended to influence or change control of the issuer, which can reduce uncertainty regarding potential activist actions.

Negatives

• The filing itself does not present negative financial or operational information about Fulgent Genetics, Inc. It is a disclosure of ownership.
• Without prior filings, it is not possible to determine if the reported ownership represents an increase or decrease from previous periods, which could be interpreted positively or negatively.

Risks

• The filing does not detail specific risks related to Fulgent Genetics, Inc.'s operations or financial health.
• The primary risk implied by such a filing is the potential for changes in institutional ownership, which could impact stock price if a large holder decides to significantly reduce its stake.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that institutional ownership by prominent hedge funds like Millennium Management LLC can signal a level of confidence in a company's long-term prospects within its sector. For Fulgent Genetics, a company in the dynamic biotechnology and diagnostics space, such a stake from a sophisticated investor suggests ongoing scrutiny and potential belief in its market position or future growth, even if the investment is passive.

Stakeholder Impact

• Shareholders: The continued passive ownership by a major institutional investor like Millennium Management LLC may provide a degree of stability and confidence, as it suggests a professional assessment of the company's value.
• Management: The passive nature of the investment indicates no immediate pressure for strategic or operational changes from this particular shareholder group.

Key Dates

Recommendation

The filing is a routine disclosure of beneficial ownership by a significant institutional investor. It does not contain new information regarding the issuer's financial performance, strategic direction, or operational changes that would warrant a 'buy' or 'sell' recommendation. The continued passive stake by Millennium Management LLC suggests a neutral to slightly positive view, supporting a 'hold' recommendation for existing investors.

Keywords

Fulgent Genetics, FGHT, Millennium Management, Integrated Core Strategies, Israel A. Englander, Schedule 13G, Beneficial Ownership, Institutional Investor, Genetics, Biotechnology